Skip to main content

Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection Images

Generic Name: ranibizumab

This medication has been identified as Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection. It is supplied by Biogen.

Byooviz is used in the treatment of Macular Degeneration; Macular Edema Following Retinal Vein Occlusion ; Macular Edema; Myopic Choroidal Neovascularization and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection medicine

Byooviz

Generic Name
ranibizumab
Strength
0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection
Availability
Prescription only
Drug Class
Anti-angiogenic ophthalmic agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Biogen
National Drug Code (NDC)
64406-0019

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.